Skip to content

Drug interactions

Infliximab + Ponesimod

Severity: Moderate

Infliximab and Ponesimod: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ponesimod lowers circulating lymphocyte counts by sequestering them in lymphoid tissue, and infliximab adds TNF-alpha blockade. Combined use may increase susceptibility to infection.

What this interaction means in plain words

Infliximab and Ponesimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Infliximab belongs to Musculoskeletal; Ponesimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive immunosuppression: S1P receptor modulation with lymphocyte sequestration plus TNF-alpha inhibition.

What to do

Monitor for infection and check lymphocyte counts while on both drugs. Consider infliximab's prolonged immune effects when starting or switching therapy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Infliximab and Ponesimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Infliximab with Ponesimod?

MediHelp rates the interaction as moderate. Infliximab and Ponesimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ponesimod lowers circulating lymphocyte counts by sequestering them in lymphoid tissue, and infliximab adds TNF-alpha blockade. Combined use may increase susceptibility to infection.

How serious is the interaction between Infliximab and Ponesimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for infection and check lymphocyte counts while on both drugs. Consider infliximab's prolonged immune effects when starting or switching therapy.

What other medicines interact with Infliximab?

MediHelp also lists interactions of Infliximab with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine. The full list is on the Infliximab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in